Treating a patient with pan-resistant Acinetobacter: a case study

Abstract

Acinetobacter has emerged as a highly important organism in global healthcare, owing to its propensity to develop pan-resistance. This resistant pathogen poses a significant challenge to healthcare professionals because it not only restricts patient care through ineffective treatment modalities but also leads to high mortality and morbidity rates. The case of a 22-year-old young man reporting to the Emergency department (ER) of Pakistan Institute of Medical Sciences (PIMS), Islamabad, on 6^th June, 2023 is presented. He complained of fever accompanied with seizures which gave a suspicion of autoimmune encephalitis or viral haemorrhagic fever. Despite initial therapeutic interventions, the patient's condition worsened, prompting further investigations. Culture and sensitivity testing of tracheal secretions revealed pan-resistance, and subsequent treatment with a combination of antibiotics including Tigecycline and Colistin, yielded a favourable response.

---Continue